Curanex Pharmaceuticals Q1 EPS $(0.11) Down From $(0.01) YoY

Benzinga Newsdesk www.benzinga.com Negative 97.3%

Neg 97.3% Neu 0% Pos 0%

Curanex Pharmaceuticals (NASDAQ:CURX) reported quarterly losses of $(0.11) per share. This is a 1000 percent decrease over losses of $(0.01) per share from the same period last year.